Clinical Trials Directory

Trials / Conditions / Stimulant Use Disorder

Stimulant Use Disorder

19 registered clinical trials studyying Stimulant Use Disorder13 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingRepetitive Transcranial Magnetic Stimulation Treatment of Stimulant Use Disorder
NCT07112105
VA Office of Research and DevelopmentN/A
Not Yet RecruitingRESTORE Study R61 Phase: Recovery and Engagement for Stimulant Users on Re-entry
NCT07136363
University of Texas Southwestern Medical CenterN/A
Not Yet RecruitingLDART for Stimulant Use Disorder
NCT07221396
Yale UniversityN/A
Not Yet RecruitingEmotional Brain Training for Addiction Medicine Treatment - A Pilot Study
NCT07001371
Loma Linda UniversityN/A
Enrolling By InvitationDeveloping and Testing Innovative Care Pathways for Screening and Treatment of OUD/PTSD in Jails
NCT07490717
University of ArkansasN/A
RecruitingSmartphone Services for Stimulant Use Disorder
NCT07092059
DynamiCare HealthN/A
RecruitingreSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COS
NCT05958017
University of MiamiN/A
Not Yet RecruitingPEX010-Assisted Therapy for Stimulant Use Disorder: A Safety, Feasibility and Efficacy Study
NCT06666010
Filament Health Corp.Phase 2
RecruitingOptimizing Transcranial Magnetic Stimulation for Stimulant Use Disorder
NCT06790576
University of MinnesotaPhase 1
RecruitingContinuum of Care in Hospitalized Patients With Opioid/Stimulant Use Disorder and Infectious Complications Fro
NCT06513156
Elana RosenthalN/A
RecruitingOrexin Receptor Antagonism and Sleep in Stimulant Use Disorder
NCT06444256
The University of Texas Health Science Center, HoustonPhase 2
RecruitingMirtazapine for the Treatment of Methamphetamine Use in Opioid Use Disorder Patients Receiving Medication Assi
NCT06323837
Washington State UniversityPhase 2
Active Not RecruitingStudy of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder
NCT05322954
University of Wisconsin, MadisonPhase 1
RecruitingBehavioral Effects of Drugs (Inpatient): 43 (Opioids, Cocaine, n-Acetylcysteine)
NCT05610072
William StoopsEARLY_Phase 1
CompletedSuvorexant for Opioid/Stimulant Co-use
NCT05546515
Johns Hopkins UniversityPhase 2
Active Not RecruitingContingency Management for Opioid and Stimulant Use Disorders in Primary Care
NCT05288751
University of MinnesotaN/A
CompletedAddressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among
NCT05286879
Yale UniversityN/A
CompletedrTMS for Stimulant Use Disorders
NCT04907357
Medical University of South CarolinaN/A
TerminatedTreating Stimulant Addiction With Repetitive Transcranial Magnetic Stimulation
NCT04228276
VA Office of Research and DevelopmentN/A